XML 47 R75.htm IDEA: XBRL DOCUMENT v2.4.0.6
Intangible Assets and Goodwill (Details Textual) (USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Acorda
Dec. 31, 2012
Acorda
Mar. 08, 2012
Stromedix, Inc.
Dec. 31, 2012
VP One Protein
Dec. 31, 2011
VP One Protein
Collaborative arrangements and non-collaborative arrangement transactions              
Business acquisition purchase price allocation to IPR&D         $ 219.2    
Business acquisition purchase price allocation goodwill amount         48.2    
Expected usage-based royalties to be earned through 2016 from license agreement           71.5  
Intangible asset recognized to reflect the total of upfront and other time-based milestone payments expected to be made 4,033.2 3,807.5       25.7 19.2
Total milestone payments     25.0        
Expected additional milestone payments when certain sales threshold is met       15.0      
Foreign sales required to trigger milestone       100.0      
Accumulated impairment losses related to goodwill $ 0